SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is experiencing extreme volatility, fueled by geopolitical tensions driving the oil sector and a recently announced $5.50 private placement. The community is sharply divided, with bulls shrugging off the offering and anticipating further parabolic short squeezes, while bears warn of an imminent crash to the offering price.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending following its recent report of record full-year 2025 revenue and significant profitability improvements, alongside a growing AI infrastructure pipeline and a new Saudi Arabia MoU. The community is sharply divided, with bulls highlighting the stock's "undervalued" status and tight float for a potential rally, while skeptics express frustration over past promises and volatile price action despite strong financials, amidst broader market pressures on small-cap tech.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB (MDB) is a major talking point after its Q4 earnings beat was met with a significant sell-off, driven by cautious forward guidance and news of leadership changes, amidst broader SaaS sector scrutiny. Community sentiment is deeply split between those eager to buy the dip, seeing an overreaction, and others who view the correction as warranted for the company's valuation.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending amidst escalating geopolitical tensions, driving oil prices higher and sparking community anticipation for a massive short squeeze akin to other energy plays like BATL and TPET. Despite some concerns about potential manipulation and dilution, many bulls are actively discussing buying the dips and holding, expecting a significant breakout as oil markets heat up.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing a sharp decline driven by escalating geopolitical tensions in the Middle East and a surging VIX, fueling widespread bearish sentiment and predictions of a significant market correction, though some anticipate a swift rebound.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

The stock is experiencing a surge following a robust Q4 earnings beat showcasing remarkable growth in USDC circulation and adjusted EBITDA, further fueled by optimistic analyst upgrades. Community discussion is actively debating its role as the payment standard for burgeoning AI agentic commerce and the potential for a continued short squeeze, contrasting with calls for a significant pullback after its recent rapid ascent.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is a hot topic as geopolitical tensions and upcoming Nvidia earnings create a polarized debate among traders. Many see a buying opportunity fueled by continued AI demand, while others caution against a "triple top" near $70-$72 and question the sustainability of semiconductor valuations.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending following its Q4 earnings report, which saw an EPS beat and optimistic full-year guidance from the new CEO, Michael Fiddelke, who is spearheading a growth-focused turnaround; however, community sentiment remains mixed amid concerns over comparable sales and store experience.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics Inc. is trending amid recent major battery orders and the operational launch of a new production facility, solidifying its role as a crucial supplier in the accelerating defense and autonomous underwater vehicle sector. The community is actively discussing its strong ties to players like Anduril, proprietary technology, and the potential for uplisting to major exchanges, which continues to drive new highs and significant long-term interest.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is experiencing significant post-earnings volatility; despite reporting a double beat on Q3 estimates and raising overall guidance, the stock sold off as investors perceived its Q4 sales forecast as a slowdown. This has sparked a community debate, with many viewing the dip as an overreaction and a compelling buying opportunity within the AI infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Citi raised its price target to $200, marking the first boost since the company’s softer fiscal 2027 revenue outlook.</li><li>Aside from Citi’s modest increase, major brokerages cut price targets, while maintaining bullish long-term AI views.</li><li>The company authorized a $50 billion buyback, raised its dividend, and signaled continued acquisitions.</li></ul>Shares of Salesforce Inc. (CRM) slipped nearly 2% in premarket trading on Tuesday, even as Citi became the first brokerage to raise its price target since the company’s softer revenue outlook rattled investors last week, underscoring lingering investor caution around AI disruption.<a href="https://stocktwits.com/symbol/CRM">CRM stock</a> posted its second consecutive session on losses on Monday, sliding nearly 1% to end at $192.95.<h2 class="st-heading-2">CRM Gets First Target Hike Since Q4 Print</h2>Citi raised its price target on Salesforce to $200 from $197, implying a 4% upside from current levels, and maintained a ‘Neutral’ rating after updating its model post-earnings. The slight increase marks the first price target hike since Salesforce forecast fiscal 2027 revenue of $45.8 billion to $46.2 billion, with the midpoint slightly below analyst expectations.&nbsp;<h2 class="st-heading-2">CRM Price Target Cuts Spread Across Wall Street</h2>With the exception of Citi’s small price target increase and ‘Neutral’ rating, most brokerages trimmed targets following Salesforce’s softer fiscal 2027 outlook, though many kept bullish ratings and pointed to longer-term AI potential.Goldman Sachs lowered its target to $281 from $330 and maintained a ‘Buy’ rating, saying the key question is whether Salesforce can turn Agentforce into “durable growth versus newer competitors.” Piper Sandler, which kept an ‘Overweight’ rating while cutting its target to $250, said guidance of 10.5% growth “is likely not changing minds” as investors question whether “AI is eating software-as-a-service.”Wedbush, reiterating an ‘Outperform’ rating despite reducing its target to $325, called Salesforce a long-term AI winner but said the stock sits at the “epicenter of the AI Ghost Trade selloff for software.” JPMorgan, with an ‘Overweight’ rating, described the quarter as “static” but noted internal metrics are improving.On the more cautious end, RBC Capital cut its target to $210 and kept a ‘Sector Perform’ rating, calling shares “fully valued,” while Bernstein maintained an ‘Underperform’ rating and pointed to guidance implying slight organic growth deceleration.Other firms lowering price targets included Truist, DA Davidson, Baird, BMO Capital, Mizuho, TD Cowen, Canaccord, Oppenheimer, BTIG, Stifel, Roth Capital, Wells Fargo and Barclays.<h2 class="st-heading-2">CEO Touts AI Growth Amid SaaS Disruption Fears</h2>Salesforce has become a focal point in Wall Street’s debate over whether AI will erode traditional software business models. Despite near-term growth concerns, Salesforce struck a confident tone on its earnings call, highlighting AI traction, large-deal momentum and stepped-up capital returns.&nbsp;The company reported fourth-quarter (Q4) earnings per share (EPS) of $3.81, beating estimates of $3.05, on revenue of $11.2 billion. Current remaining performance obligations (RPO) rose 16% year over year to $35.1 billion, while total RPO rose 14% to $72 billion.CEO Marc Benioff called it a “phenomenal quarter” and said the company is “well on our way” to reaching $63 billion in annual revenue by fiscal 2030. Annual recurring revenue of Agentforce, the company’s AI automation platform, climbed to $800 million, up from $500 million in the prior quarter, with record bookings and 29,000 deals closed. The company reiterated expectations for “organic growth re-acceleration” in the second half of fiscal 2027.Salesforce authorized a new $50 billion share repurchase program and raised its quarterly dividend 5.8% to $0.44 per share. The company said the balance sheet is “very underleveraged,” and signaled continued acquisitions.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for CRM was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/crm_ss_png_3e08f5ed0d.webp" alt="crm ss.png" width="972" height="140"><figcaption>CRM sentiment and message volume as of March 3 | Source: Stocktwits</figcaption></figure>One bullish user&nbsp;<a href="https://stocktwits.com/Bargainhunters/message/646362762">said</a>, “The buy-backs have ensured the floor. It’s only upwards from here. Slow and steady as the company slowly vacuums the cheap stocks till they are no more cheap.”&nbsp;<stembedurl>https://stocktwits.com/Bargainhunters/message/646362762</stembedurl>Another user <a href="https://stocktwits.com/TFars/message/646329473 ">said</a>, “You can believe the A.I. won’t disrupt all these SAAS companies. It’s harder to believe that productivity gains won’t equal considerable license declines.”<stembedurl>https://stocktwits.com/TFars/message/646329473</stembedurl>CRM stock has declined 27% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Salesforce logo is displayed at the 8th China International Import Expo. (Photo by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Salesforce Stock Slips Premarket: First Price Target Hike Since Revenue Warning Fails To Revive Bulls

Wall Street remains split on whether AI will accelerate Salesforce’s growth or pressure traditional SaaS models, with Agentforce seen as a key test.

Why Is CRM Stock Slipping Premarket Today?

Equity

<ul class="summary-bullets"><li>Robert F. Kennedy Jr. said the FDA is reviewing restrictions on peptides, with about 14 potentially returning to a category that allows U.S. compounding in the coming weeks.</li><li>Kennedy told The Joe Rogan Experience he hopes peptides will be accessible through “ethical suppliers.”</li><li>The company said on its latest earnings call that GLP-1 users represent only a small portion of subscribers.</li></ul>Shares of Hims &amp; Hers Health, Inc. (HIMS) jumped on Monday after Robert F. Kennedy Jr. said the U.S. Food and Drug Administration (FDA) is reviewing the status of several peptides that were previously restricted, signaling a potential reopening of a fast-growing category that analysts say could benefit the digital health company.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> jumped nearly 14% on Monday, posting its best session in over four months, to end at $16.48.&nbsp;<h2 class="st-heading-2">Peptide Reclassification Review Underway</h2>Speaking on The Joe Rogan Experience, Kennedy said that nearly two dozen peptides had previously been moved to a restricted category, preventing U.S.-based compounding pharmacies from legally producing them. He said the FDA is now considering moving roughly 14 of those peptides back to a category that would allow domestic compounding.“My hope is that they’re going to get moved to a place where people have access from ethical suppliers,” Kennedy said, while acknowledging that the scientific evidence supporting some uses of the peptides “hasn’t been fully gathered.”Kennedy argued that the earlier restriction contributed to a surge in gray-market sourcing. “We created the black market,” he said, describing how patients seeking peptides turned to unregulated suppliers once legal compounding options were removed.&nbsp;Peptides are short chains of amino acids that play a key role in regulating biological functions. Certain varieties are marketed for potential benefits, such as supporting muscle growth, enhancing immune response, and promoting healthier aging, though their effectiveness can vary by compound and clinical evidence.He said the original decision was framed around regulatory authority but maintained that safety concerns had not changed. According to Kennedy, the review underway could result in formal changes within the next few weeks. Kennedy added that he is personally supportive of peptide therapies, saying he is “a big fan of peptides” and has used them himself for injury recovery.The development comes as policymakers also examine broader therapeutic categories, including psychedelics and other non-traditional treatments, as part of a push to modernize access to certain therapies under tighter guidelines.<h2 class="st-heading-2">Peptide Shift A ‘Gamechanger’ For HIMS</h2>The Futurum Group CEO Daniel Newman&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/danielnewmanUV/status/2028393809340469618">said on X</a> that Hims “is the most likely public company play for peptides at scale” and said the category “could easily offset any GLP-1 related downside.”Jonah Lupton, CEO and CIO of Lupton Capital, called the development a “gamechanger for the company and the stock price,”&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/JonahLupton/status/2028283530933911998">on X</a> and said that moving 14 peptides back to Category-1 would allow U.S.-based compounding pharmacies to produce and sell them without risk of shutdown.Lupton said the shift could bring “transparency, safety and accountability” to a market he expects to surpass $100 billion by 2030. He noted that Hims &amp; Hers acquired a U.S.-based peptide facility in California last year and now serves roughly 2.5 million members.“With 2.5 million members and growing (thanks to recent acquisitions),<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/search?q=%24HIMS&amp;src=cashtag_click"> $HIMS</a> is well positioned to capitalize on the peptide boom that I believe is about to take off around the world,” Lupton said.<h2 class="st-heading-2">CEO: GLP-1 A Small Share Of Subscribers</h2>The renewed focus on peptides comes as Hims &amp; Hers continues to navigate scrutiny around compounded GLP-1 offerings. On its most recent&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-slumps-after-hours-how-ceo-dudum-plans-to-offset-glp-1-risk/cZRviIhR4z3">earnings call</a>, CEO Andrew Dudum said that GLP-1 users who are on a compounded regimen represent only a small minority of the company’s subscriber base. The company pointed to expansion across hormone therapy, lab diagnostics, dermatology, sexual health and menopause care as part of a broader preventive-health strategy.The company reiterated long-term financial targets of at least $6.5 billion in revenue and $1.3 billion in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) by 2030, while noting that its 2026 outlook assumes continued access to compounded semaglutide.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for HIMS was ‘neutral’ amid ‘low’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/hims_ss_png_d444f7a0ca.webp" alt="hims ss.png" width="973" height="139"><figcaption>HIMS sentiment and message volume as of March 3 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/RaihanMeazza/message/646391054">said</a>, “We're waiting for the market to cool off. Then, this will have a run!”<stembedurl>https://stocktwits.com/RaihanMeazza/message/646391054</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Pedje/message/646370934">said</a>, “peptides is the future. I lost 20 lbs on two months from taking Glp-3”<stembedurl>https://stocktwits.com/Pedje/message/646370934</stembedurl>HIMS stock has declined nearly 50% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Hims & Hers Health in front of a screen showing the company's stock market chart. (Photo illustration by Cheng Xin/Getty Images)

Hims & Hers Finds A GLP-1 Hedge? HIMS Stock Rallies As RFK Jr. Signals Peptide Clearances

The Futurum Group CEO Daniel Newman said Hims is the “most likely public company play” for peptides at scale.

<ul class="summary-bullets"><li>Founder and executive chairman Patrick Soon-Shiong called a rare public speech his “prelude” to Tuesday’s earnings update.</li><li>The company is set to report FY25 results on Tuesday, with estimates pointing to revenue of $113.3 million versus $14.8 million in 2024 and narrowing losses.</li><li>Anktiva generated $113 million in net product revenue in 2025, up 700% year over year, while Q4 revenue climbed 431% to $38.3 million.</li></ul>Shares of ImmunityBio, Inc. (IBRX) extended their three-day rally on Monday, with founder and executive chairman Patrick Soon-Shiong adding fuel to the stock by calling a rare public speech a “prelude” to its earnings update due Tuesday.<a href="https://stocktwits.com/symbol/IBRX">IBRX stock</a> rose nearly 7% on Monday to end at $10.44 and slipped slightly in extended trading.&nbsp;<h2 class="st-heading-2">IL-15 Spotlighted As Anktiva’s Core Engine</h2>Soon-Shiong&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/DrPatrick/status/2028658871623905656">said on X</a> that his remarks from last week, delivered at an event marking the 55th anniversary of President Richard Nixon’s “war on cancer,” were a “prelude” to ImmunityBio’s upcoming earnings.He criticized decades-old cancer treatment strategies, arguing that many chemotherapy drugs were developed without fully accounting for the immune system. He said high-dose chemo and radiation can significantly reduce vital immune cells like NK cells and T cells, creating a condition known as lymphopenia.&nbsp;He called the absolute lymphocyte count (ALC), a blood-test metric, “hidden in plain sight,” saying immune depletion has been underappreciated despite its measurability.Soon-Shiong also criticized major cancer drugs, citing Taxol, which is marketed by Bristol Myers, and Amgen’s Neupogen. He argued that these approaches reflected an industry-wide strategy of enabling more intensive chemotherapy and managing its side effects, rather than addressing underlying immune suppression.Against that backdrop, he spotlighted IL-15 as the biological engine behind Anktiva, positioning it as an immune amplifier rather than a traditional therapy. He contrasted older IL-2 approaches with IL-15 biology, saying IL-15 expands natural killer cells and memory cells without boosting immunosuppressive cells.&nbsp;<h2 class="st-heading-2">IBRX 2025 Results Preview</h2>ImmunityBio is set to report full-year&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibrx-stock-eyes-green-open-ahead-of-earnings-what-happened-with-anktiva-over-the-weekend/cZddUNHRIcl">2025 earnings</a> on Tuesday, with expectations for sharply higher revenue and narrowing losses as Anktiva's commercialization scales.Fiscal AI estimates 2025 revenue of $113.29 million, up from $14.75 million in 2024, with loss per share improving to $0.38 from $0.59. The company has indicated $113 million in net product revenue for Anktiva in 2025, up 700% year over year, while fourth-quarter revenue rose 431% to $38.3 million, topping estimates. Full-year net loss attributable to common shareholders improved to $351.4 million from $413.6 million in 2024.<h2 class="st-heading-2">Regulatory Wins Bolster Anktiva Outlook</h2>Soon-Shiong has recently amplified Anktiva’s IL-15 mechanism in national media appearances and highlighted combination approaches with checkpoint inhibitors such as Merck’s Keytruda.&nbsp;ImmunityBio recently completed enrollment ahead of schedule in its Phase 2 Quilt 2.005 trial evaluating Anktiva plus BCG in early-stage bladder cancer, citing improved cancer-free rates compared with standard BCG alone. A biologics license application for the regimen is expected by the fourth quarter of 2026.Anktiva is already approved in combination with BCG for bladder cancer in the U.S. and has received authorizations in the UK, Europe, and Saudi Arabia, where regulators also granted accelerated approval for use with a checkpoint inhibitor in metastatic non-small cell lung cancer.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for IBRX was ‘bullish’ amid a 185% jump in 24-hour message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/ibrx_ss_png_09ff793a38.webp" alt="ibrx ss.png" width="967" height="144"><figcaption>IBRX sentiment and message volume as of March 3 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/PureLand/message/646395463">said</a> that, “If [broader Saudi] approval comes through, the stock could jump toward $20 quickly, and a squeeze could drive it over $100.”<stembedurl>https://stocktwits.com/PureLand/message/646395463</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/MrStockxy/message/646392467">said</a>, “Will be go[ing to] $11 tomorrow. Let’s bet.”<stembedurl>https://stocktwits.com/MrStockxy/message/646392467</stembedurl>IBRX stock has surged over 400% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook

The founder criticized traditional chemotherapy approaches from Amgen and Bristol Myers and hyped up the mechanism behind Anktiva.

<ul class="summary-bullets"><li>Last week, Rosenblatt initiated with a 'Buy' rating and $150 target, while UBS upgraded to 'Buy' with a $180 target.</li><li>PLTR shares have been on the climb after U.S.-Israel strikes on Iran lifted military-linked names.</li><li>The debate unfolds amid a broader U.S. defense AI shake-up, including a Pentagon drone swarm challenge that did not select Anthropic.</li></ul>Peter Thiel, co-founder of Palantir Technologies, Inc. (PLTR), plans to sell roughly $280 million worth of stock in the data analytics company,&nbsp;a regulatory filing shows, amid the stock’s best streak in nearly three months.<h2 class="st-heading-2">Thiel Files $280M Sale Of PLTR</h2>A new regulatory filing shows that Thiel plans to sell up to 2 million Class A shares through Merrill Lynch, Pierce, Fenner &amp; Smith, valued at $280 million&nbsp;on Tuesday.&nbsp;According to SEC filings, Thiel last shed stake in Palantir in October 2024.&nbsp;Thiel, however, has remained one of the company’s largest individual shareholders and its chairman since the company's incorporation in 2003.<h2 class="st-heading-2">Palantir Gains On Defence AI Demand Surge</h2>Shares of Palantir have risen for four straight sessions, their longest winning streak since early December, after the U.S. and Israel launched strikes on Iran, lifting defense names on concerns the conflict could drag on for weeks. With longstanding ties to U.S. defense and intelligence agencies, including a $10 billion Army contract and a $448 million Navy deal, Palantir was among the top gainers in the S&amp;P 500 on Monday.The company’s appeal lies in its dual role as both a defense contractor and an AI software provider. Bob Lang, founder of trading platform Explosive Options, noted, “They do not build weapons, missiles or planes," and added that "the big contracts for Palantir are important but likely already in the price of the stock," according to a<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://in.tradingview.com/news/DJN_DN20260302005667:0/">&nbsp;report</a> by Dow Jones.<h2 class="st-heading-2">Michael Burry’s Latest Attack On PLTR</h2>The planned sale comes a day after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/big-short-investor-michael-burry-says-us-military-s-claude-ai-phase-out-proves-pentagon-can-t-rely-on-palantir-alone/cZddrJORIcg">Burry weighed</a> in on the U.S. government’s decision to grant a six-month phase-out period for Anthropic’s Claude AI, even after designating the company a supply-chain risk. He said the episode “shows the stickiness is Claude’s tech, not Palantir’s,” suggesting the underlying AI model may be more central to defense workflows than the software layer hosting it.Burry disclosed a short position in Palantir last year and has repeatedly&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/michael-burry-targets-palantir-again-flags-nefarious-accounting-and-ceo-alex-karp-s-17-m-jet-bill/cZRjZMcR4wQ">criticized</a> the company’s valuation and accounting practices. Recently, he argued that accounts receivable have grown faster than revenue in the most recent quarters, a pattern he said can sometimes signal aggressive revenue recognition. He has also highlighted rising spending tied to CEO Alex Karp’s personal jet.<h2 class="st-heading-2">Wall Street Sees ‘Attractive’ Entry Point For PLTR</h2>Palantir’s stock has surged more than 1,400% since its debut on the NYSE in September 2020. The shares currently trade at about 110 times forward earnings and at a forward revenue multiple of more than 46.Last week, Rosenblatt initiated coverage of Palantir with a ‘Buy’ rating and a $150 price target, calling the company a “market-disrupting, uniquely positioned AI software leader.” The brokerage said Palantir has a sustainable growth trajectory and margin leverage, and views the recent pullback, with shares down about 33% from their October high, as an attractive entry point. UBS also upgraded Palantir to ‘Buy’ from Neutral with a $180 price target,&nbsp;and called it a “premier growth story” positioned at the intersection of AI and data spending, and said its recent channel checks point to a strong demand backdrop.&nbsp;<h2 class="st-heading-2">Anthropic Sidelined Amid Trump AI Crackdown</h2>Anthropic has faced mounting scrutiny from the Trump administration over military AI use and was&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-03-02/anthropic-made-pitch-in-drone-swarm-contest-during-pentagon-feud">reportedly</a> not selected for a $100 million Pentagon drone swarm challenge, with bids tied to SpaceX and OpenAI advancing instead.&nbsp; Meanwhile, consumer demand for Claude has surged, with free active users up over 60% since January and daily signups quadrupling, prompting Anthropic to expand features to retain new users.<h2 class="st-heading-2">How Did PLTR Stocktwits Followers React?</h2>On Stocktwits, retail sentiment for PLTR was ‘neutral’,&nbsp;improving from ‘bearish’ a day ago, amid ‘normal’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/pltr_ss_png_e6a7d018ab.webp" alt="pltr ss.png" width="969" height="142"><figcaption>TSLA sentiment and message volume as of March 3 | Source: Stocktwits</figcaption></figure>"Peter Thiel's sale of ~2 million shares of Palantir Technologies was part of a pre-arranged Rule 10b5-1 trading plan,"<a href="https://stocktwits.com/matuli/message/646393097">&nbsp;posted</a> one bullish user. "So this was a structured, planned sale — not a sudden discretionary move based on new inside knowledge."<stembedurl>https://stocktwits.com/matuli/message/646393097</stembedurl>"PLTR should continue higher into the 50/200...but once the Iran thing is done, down she goes. $115 by April, possible,"<a href="https://stocktwits.com/Dr_Stoxx/message/646373832">&nbsp;posted</a> another user, citing technical levels.<stembedurl>https://stocktwits.com/Dr_Stoxx/message/646373832</stembedurl>PLTR stock has declined 18% year-to-date, underperforming the S&amp;P 500 and the Nasdaq.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Palantir logo is displayed on a mobile phone with a financial stock graph seen in the background, in this photo illustration in Brussels, Belgium, on November 3, 2025.

Peter Thiel Plans $280M Palantir Stock Sale Amid Best Winning Streak In Months: Retail Sentiment Ticks Up On Defense Rally 

War-driven demand and Wall Street upgrades have buoyed PLTR stock.

<ul class="summary-bullets"><li>Shares plunged 24% after-hours despite a Q4 beat, as weak Q1 EPS guidance weighed on sentiment.</li><li>Atlas revenue grew 29% and crossed a $2 billion run rate for the first time, while non-Atlas revenue rose 20%, its strongest growth in two years.</li><li>Barclays called the selloff ‘overblown,’ reiterating an 'Overweight' rating and a $440 price target, which implies a 35% upside from current levels.&nbsp;</li></ul>MongoDB, Inc. (MDB) shares crashed 24% in extended trading on Monday after the database company issued first-quarter profit guidance that came in below expectations, even as it reported a fourth-quarter (Q4) beat and highlighted strong momentum in its cloud business.<a href="https://stocktwits.com/symbol/MDB">MDB stock</a> fell for the second straight session on Monday, declining over 3% to close at $325.01.<h2 class="st-heading-2">MDB Q4 Preview And Outlook</h2>MongoDB reported Q4 adjusted earnings of $1.65 per share, beating consensus estimates of $1.47 per share. Revenue came in at $695.1 million, above expectations of $669.37 million, marking a 27% increase from the previous year.Revenue from Atlas, MongoDB’s cloud database platform, grew 29% from the previous year and crossed a $2 billion run-rate for the first time, while non-Atlas revenue increased 20%, marking its strongest growth quarter in two years.CEO C.J. Desai said on the company’s earnings call that MongoDB “delivered strong fourth quarter results driven by our continued go-to-market execution and the broad-based demand we are seeing across our product lines.” He added that MongoDB achieved Rule of 40 performance, a metric in which revenue growth and operating margin exceed 40%, while also expanding operating margins.MongoDB ended the quarter with more than 65,200 customers, including 402 customers generating at least $1 million in annual recurring revenue.Despite the strong finish to fiscal 2026, the company’s guidance weighed on sentiment. For the first quarter, MongoDB expects first-quarter adjusted earnings of $1.15 to $1.19 per share, below estimates of $1.21 per share. The company guided revenue in the $659 million to $664 million range, versus expectations of about $662.5 million.For fiscal 2027, the company forecast revenue of $2.86 billion to $2.9 billion, representing 16% to 18% growth, and adjusted earnings of $5.75 to $5.93 per share. Atlas revenue is expected to grow 21% to 23% for the full year.<h2 class="st-heading-2">MongoDB Revamps Leadership</h2>MongoDB also said that chief revenue officer (CRO) Paul Capombassis and president of field operations Cedric Pech are leaving the company. Capombassis will remain through the end of the first quarter and serve as an adviser in the second quarter. The company said it is in the final stages of a search for a new CRO.Meanwhile, Erica Volini joined as the company’s chief customer officer, reporting directly to Desai. Volini previously led enterprise and partner growth initiatives at Deloitte and ServiceNow.<h2 class="st-heading-2">CEO Sees ‘Generational’ AI Opportunity</h2>On the earnings call, Desai said he had spoken with more than 200 customers globally in his first full quarter as CEO and sees MongoDB positioned to become a “generational data platform of choice in the AI and multi-cloud era.”While AI is not yet a material revenue driver, MongoDB said the number of customers using Vector Search, which enables similarity search across AI-generated data such as text and images, nearly doubled year over year.Usage of Voyage embedding models, which are AI tools that turn text and other data into formats computers can quickly search and compare, has also doubled since last February.Large deals in the quarter included a $90 million deal with a technology company expanding AI workloads on Atlas and a transaction exceeding $100 million with an undisclosed financial institution, marking the largest total contract value deal in MongoDB’s history.The company reiterated its goal of growing Atlas above 20% and maintaining Rule of 40 performance, while guiding to operating margin expansion of about 100 basis points in fiscal 2027.<h2 class="st-heading-2">Barclays Calls Selloff ‘Overblown’</h2>Barclays kept an ‘Overweight’ rating and $440 price target on MongoDB following the results, saying the post-earnings decline “seems overblown.” Based on MongoDB’s last close, Barclays’ price target implies a 35% upside.The brokerage noted that Atlas' 29% growth remained “solid,” even with a slight deceleration from 30% in the prior quarter. Barclays also pointed out that the company has taken a “conservative” approach to guidance in recent years and that the 17% fiscal 2027 growth outlook is “higher than in previous years.” Barclays said it remains positive on the company’s long-term story and views the current decline as a “buying opportunity.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for MDB was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/mdb_ss_png_0c7a921eec.webp" alt="mdb ss.png" width="965" height="141"><figcaption>MDB sentiment and message volume as of March 2 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/joedoe007/message/646387052">said</a>, “One more big dip in the AM tomorrow and then a bounce play. Let see and i wait for that big big dip.”<stembedurl>https://stocktwits.com/joedoe007/message/646387052</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/joedoe007/message/646383235">expects</a> MDB shares to open near $220 or at least fall to around that level intraday, then potentially reverse higher toward $255 by midweek. ”Lets see. So I may buy at $220 for that dead cat bounce play,” they added.&nbsp;<stembedurl>https://stocktwits.com/joedoe007/message/646383235</stembedurl>MDB stock has declined 23% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a hand holds a smartphone displaying the logo of MongoDB Inc.

MongoDB Stock Crashes After-Hours On Weak Guidance — Barclays Sees 35% Upside After 'Overblown' Pullback 

Shares fell after the company projected first-quarter adjusted earnings of $1.15 to $1.19 per share, below estimates.

<ul class="summary-bullets"><li>Trump vowed to do “whatever it takes,” while Secretary of State Marco Rubio said a cost-mitigation program would begin Tuesday.</li><li>Analyst Patrick De Haan expects retail gasoline prices to increase by $0.10 to $0.30 per gallon over the coming week.</li><li>Battalion boosted gas processing to over 30 million cubic feet per day in January, while Indonesia Energy advanced drilling plans at Kruh Block.</li></ul>Shares of Battalion Oil Corp. (BATL) and Indonesia Energy Corp. (INDO) hit their highest levels since 2022 on Monday as crude held most of its gains&nbsp;driven by the U.S.-Iran conflict, with a fuel analyst saying the move is already filtering through to retail gasoline markets.<a href="https://stocktwits.com/symbol/BATL">BATL stock</a> surged 123% on Monday, hitting its highest level since November 2022, and added more than 35% in extended trading. Meanwhile,&nbsp;<a href="https://stocktwits.com/symbol/INDO">INDO shares</a> rose 15% during the session to their highest level since October 2022 before slipping slightly in extended trade.<h2 class="st-heading-2">Oil Holds Gains As Strait Of Hormuz Threat Escalates</h2>West Texas Intermediate traded near $71 a barrel after rallying more than 6% on Monday, while Brent crude ended near $78. Oil markets were jolted after the U.S. and Israel intensified military operations against Iran and Tehran threatened a full closure of the Strait of Hormuz, which handles roughly a fifth of global oil flows.An adviser to Iran’s Islamic Revolutionary Guard Corps said forces would “set fire to any ship attempting to pass through” the strait. Tanker traffic has slowed sharply, and freight rates for Middle East crude routes surged to record levels. Energy infrastructure has also been targeted, including a halt to operations at Saudi Aramco’s Ras Tanura refinery and the shutdown of liquefied natural gas production at Qatar’s largest export facility.U.S. President Donald Trump said the U.S. would do “whatever it takes” in the conflict, while Secretary of State Marco Rubio said the campaign would intensify and a program to mitigate energy costs would begin Tuesday. The administration has no immediate plans to release crude from the Strategic Petroleum Reserve, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-03-02/us-has-no-immediate-plan-to-tap-oil-reserve-on-iran-concerns">report</a>.&nbsp;<h2 class="st-heading-2">Analyst Says Retail Gas Hikes Begin This Week</h2>While energy stocks reacted immediately to the surge in crude prices, Patrick De Haan, an analyst at GasBuddy, said the more tangible impact on consumers is just beginning.De Haan said wholesale markets have already adjusted to higher oil prices. “We now have real numbers to analyze — not just hypotheticals,” he said, noting that crude is up roughly $5 to $6 per barrel, wholesale gasoline has risen about $0.11 per gallon, and wholesale diesel has jumped $0.38 per gallon.He said this is a “risk premium being layered onto an already tightening seasonal market,” rather than a confirmed supply shock.“To be clear: I do expect prices to begin inching higher in most states today or tomorrow — and in some markets, that process is already underway,” De Haan said. “Oil moves first. Rack prices follow. Retail adjusts after that.”He expects average gasoline prices to rise by $0.10 to $0.30 per gallon over the coming week, with price-cycling markets potentially seeing sharper resets of $0.30 to $0.85 per gallon. Diesel prices could climb $0.20 to $0.35 per gallon this week, reflecting tighter distillate fundamentals.De Haan added that the geopolitical premium is landing on top of seasonal factors such as the shift to summer gasoline blends, refinery maintenance and rising demand. “Volatility? Yes. Explosive structural repricing? Not yet,” he said.<h2 class="st-heading-2">BATL, INDO Track Oil’s War-Driven Spike</h2>In January, Battalion terminated its gas treating agreement with Wink Amine Treater after the prior facility ceased operations and entered into a new agreement with a large-cap midstream provider. Following a fourth-quarter expansion, the alternate facility processed more than 30 million cubic feet of gas per day in January, up from about 17.4 million cubic feet per day in December. Battalion said “additional flow assurance and operational reliability” contributed to a roughly 1,200 net barrels of oil per day increase month-to-date in January versus December levels.On the other hand, Indonesia Energy reported pre-drilling progress on two wells at its Kruh Block and said it remained on track to begin drilling before the end of the first quarter of 2026, with wells expected to be drilled back-to-back.&nbsp;In October 2025, the company signed a memorandum of understanding to explore hybrid solar and natural gas energy projects in Brazil with a potential initial capacity of 10 megawatts and expansion up to 400 megawatts.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for BATL and INDO was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/batl_ss_png_8643cab2bb.webp" alt="batl ss.png" width="970" height="140"><figcaption>BATL sentiment and message volume as of March 2 | Source: Stocktwits</figcaption></figure><figure class="image"><img src="https://news.stocktwits-cdn.com/indo_ss_png_626d861779.webp" alt="indo ss.png" width="969" height="145"><figcaption>INDO sentiment and message volume as of March 2 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Gypsea/message/646383729">said</a> BATL will “be in the 25 to 35 range in the next week or two... The war has just started, and it's going to be four or five weeks and more, who knows with Trump at the helm... We could see $120 a barrel.”<stembedurl>https://stocktwits.com/Gypsea/message/646383729</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/mrshine2/message/646384199">said</a> his “realistic target” for INDO is $15, and added that it would “be nice to hit $21. Oil and energy is the play this year in my opinion.. AI will come back next year lol”<stembedurl>https://stocktwits.com/mrshine2/message/646384199</stembedurl>While BATL has skyrocketed by more than 900% so far this year, INDO has more than doubled over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

An offshore oil platform is seen at sunset on February 9, 2024 near Huntington Beach, California.

BATL, INDO Stocks Hit Over 3-Year Highs As Strait Of Hormuz Fears Lift Oil — Analyst Says Retail Gas Hikes Begin This Week

WTI hovered near $71 and Brent near $78 after threats to close the Strait of Hormuz.

<ul class="summary-bullets"><li>Nasdaq 100 futures were down 0.4%, S&amp;P 500 futures fell 0.3% and Dow futures slipped 0.2%.</li><li>WTI surged as much as 6.3% to $71.23 and Brent ended near $78 after threats to the Strait of Hormuz.</li><li>Defense and energy firms, including Northrop Grumman, Lockheed Martin, Exxon Mobil and Chevron led gains on Monday.</li></ul>U.S. stock futures edged lower Monday night as traders weighed escalating U.S.-Iran tensions, surging oil prices and shifting rate-cut expectations after a volatile rebound session.As of 7.45. p.m. ET, Nasdaq 100 futures were down 0.4%, while S&amp;P 500 futures&nbsp;were down by 0.3%. Dow futures were down 0.2%.On Stocktwits, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust (SPY)</a> was ‘neutral,’ the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> was ‘bearish,’ and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> was ‘extremely bearish,’ with all ETFs in the ‘high’ message volume zone.<h2 class="st-heading-2">US Market Drivers</h2>Futures fell after a dramatic Monday in which stocks rebounded from steep intraday losses tied to widening hostilities between the U.S. and Iran.The S&amp;P 500 ended Monday up 0.04% after falling as much as 1.2% earlier in the session. The Nasdaq Composite advanced 0.4%, reversing a drop of as much as 1.6%. The Dow Jones Industrial Average fell 0.2%, but had been down nearly 600 points at its low.The rebound came as U.S. crude prices retreated from session highs, easing immediate concerns about a deeper economic shock. Still, oil markets remained volatile. West Texas Intermediate jumped as much as 6.3% to settle at $71.23, while Brent crude ended near $78, up nearly 8%, after an Iranian Revolutionary Guard adviser warned forces would “set fire to any ship attempting to pass through” the Strait of Hormuz.&nbsp;The chokepoint handles roughly a fifth of global oil flows, and tanker traffic has slowed sharply amid security fears.The conflict intensified after joint U.S.-Israeli strikes killed Iran’s Supreme Leader Ayatollah Ali Khamenei over the weekend. U.S. President Donald Trump said the military operation was the nation’s “last, best chance to strike” and that the U.S. would do “whatever it takes,” projecting the war could last four to five weeks, or “far longer than that.”&nbsp;Energy infrastructure across the region has been targeted, with Saudi Aramco halting operations at its Ras Tanura refinery following a drone strike and Qatar suspending production at the world’s largest LNG export facility after an attack.&nbsp;Traders are now fully pricing in a first Federal Reserve rate cut in September, with expectations for additional cuts in 2026 fading.Defense and energy stocks led gains Monday, with Northrop Grumman rising about 6% and Lockheed Martin climbing more than 3%. Energy majors Exxon Mobil and Chevron also climbed. Nvidia rose nearly 3% and Microsoft gained 1.5%, helping stabilize the broader market. Just four of the S&amp;P 500’s 11 sectors closed positive, including energy, industrials, technology and real estate.Carson Investment Group&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/CarsonResearch/status/2028575261969514641">said on X</a> that “the headlines from the Middle East are heavy, but the market’s reaction has been measured so far.” The firm noted that geopolitical events “rarely end bull markets,” adding that near-term volatility is the “price” of entry and said recoveries are often swifter than expected.The research firm said February already showed a “risk-off” move, with energy and utilities leading, gold up 13% year to date, and small caps and Bitcoin under pressure, suggesting some of the conflict was partially priced in. “We aren't changing our base case for a 12-15% S&amp;P 500 return in 2026. Seasonality is tough in early March, but data suggests staying the course,” Carson said.&nbsp;<h2 class="st-heading-2">Trending Stocks To Watch On NYSE, Nasdaq</h2>Battalion Oil (BATL): Shares surged 123% on Monday, hitting their highest levels since November 2022, and jumped more than 35% in extended trading, as oil spiked on Strait of Hormuz closure fears. Stocktwits&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/battalion-oil-stock-more-than-doubles/cZd3lOjRI2S">sentiment</a> was in the “extremely bullish” territory amid “extremely high” message volume.Poet Technologies (POET): The stock rose more than 12% in regular trading and added over 4% after-hours following&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/poet-shares-surged-today-nvidia-connection/cZd3KaZRI2L">Nvidia’s partnership</a> with Coherent to advance optics technologies for AI data center infrastructure.MongoDB (MDB): Shares tumbled more than 24% in extended trading despite topping fourth-quarter (Q4) earnings and revenue estimates, as investors reacted to its first-quarter earnings per share (EPS) guidance of $1.15 to $1.19, which came in below expectations.Gorilla Technology Group (GRRR): The stock gained over 1.5% after-hours following record full-year&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/grrr-shares-gain-after-hours-on-breaching-100m-annual-revenue-mark/cZd3nH6RI2V">2025 revenue</a> of $101.4 million and adjusted EPS of $0.89, while highlighting a $7 billion pipeline tied to AI and GPU infrastructure opportunities.Indonesia Energy Corp (INDO): Shares hit their highest levels since October 2022 during Monday’s session as escalating Middle East tensions and threats to the Strait of Hormuz boosted expectations for sustained oil price strength.<h2 class="st-heading-2">How Global Markets Are Performing Today</h2>In broader markets, the yield on the benchmark 10-year U.S. Treasury note stood near 4.03%, while gold traded around $5,343 an ounce after rising for a fifth straight day. Silver hovered near $89.87, with platinum and palladium also higher.West Texas Intermediate crude was slightly lower near $71 a barrel in early Asian trade after Monday’s surge, while Brent held near $78.MSCI’s broadest index of Asia-Pacific shares outside Japan fell 0.75% to 808.04. Shares in Japan declined, while Australian markets opened lower. However, Hong Kong futures pointed higher and South Korean markets are set to resume trading after a long weekend.Among the catalysts for the day are New York Fed President John Williams' remarks, Kansas City Fed President Jeff Schmid's speech, and Minneapolis Fed President Neel Kashkari's interview. Investors are also awaiting quarterly earnings from CrowdStrike and Target on Tuesday, with results from Broadcom and Costco due later this week.&nbsp;On the economic front, vehicle sales data are expected on Tuesday, mortgage applications on Wednesday, import prices on Thursday, and the U.S. employment report on Friday.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Vantor satellite image shows the damaged sections and burnt areas of the Ras Tanura oil refinery following an incident. (Photo credit: Getty Images)

Dow, S&P 500, Nasdaq Futures Slip As Strait Of Hormuz Fears Linger: Why BATL, MDB, POET, GRRR, INDO Are Trending After-Hours

Investors now await Fed speeches, CrowdStrike and Target earnings, and a week of economic data capped by Friday’s jobs report.

<ul class="summary-bullets"><li>Burry compared CoreWeave’s model to Level 3 Communications from the dot-com era, arguing its infrastructure-heavy economics may be even more challenging over time.</li><li>The caution came after Q4 results missed expectations and the company outlined aggressive 2026 capex plans.</li><li>CEO Mike Intrator defended the investment cycle, saying demand from enterprise and sovereign AI clients remains strong.</li></ul>Shares of CoreWeave, Inc. (CRWV) fell 4% in premarket trading on Monday after “The Big Short” investor Michael Burry warned the company resembles past tech bubble plays, even as analysts remained bullish on long-term growth.<a href="https://stocktwits.com/symbol/CRWV">CRWV stock</a> fell over 18% on Friday to $79.56, marking its worst session in over six months, and fell another 0.2% in extended trade.<h2 class="st-heading-2">Burry Draws Dot-Com Parallel</h2>In a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://substack.com/@michaeljburry/note/c-220488532">Substack note</a> on Friday, Burry said CoreWeave “exists as an off-balance sheet SPV&nbsp;[special purpose vehicle]&nbsp;designed to lose money,” adding that enthusiasm around AI spending had pushed the company into public markets.He compared the business model to Level 3 Communications during the last technology bubble, saying that CoreWeave may be in an even more challenging position because its infrastructure depreciates faster. Burry added that the company’s infrastructure economics could prove more demanding over time, suggesting the comparison was “so obvious it is almost not interesting enough to discuss.”The remarks came shortly after CoreWeave reported fourth-quarter (Q4) results that missed expectations and outlined plans for higher investment.<h2 class="st-heading-2">Spending Plans Raise Questions</h2>The company posted a Q4 loss of $0.56 per share on revenue of $1.57 billion, compared with expectations for a $0.49 loss on $1.53 billion in revenue, according to Fiscal.ai data.At the same time, CoreWeave projected capital expenditures of $30 billion to $35 billion for 2026, more than double the $14.9 billion spent in 2025. Its first-quarter revenue outlook of $1.9 billion to $2 billion also fell short of Wall Street’s $2.24 billion estimate.CEO Mike Intrator&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/coreweave-ceo-justifies-capex-spend-amid-stock-price-plummet-touts-high-demand/cZTcYsFRIT8">defended</a> the company’s spending plans, telling CNBC that demand for infrastructure has been “relentless” as enterprise and sovereign customers scale AI deployments.“Our clients are increasing the demand signals that they are giving us,” Intrator said, adding that the company had made an “intentional decision” to expand infrastructure even if it pressures margins. He also acknowledged investor concerns around the scale of the company’s spending, but said the investment reflects an “enormous” backlog.<h2 class="st-heading-2">Wall Street Sees Up To 98% Upside</h2>Following the earnings miss and capital intensity outlook, JPMorgan lowered its target to $90 from $110, implying an upside of about 18.5% from the stock’s last close, while maintaining a Neutral rating. The brokerage cited a more “pronounced” investment cycle.Mizuho cut its target to $95 from $100, suggesting an upside of roughly 25.1% from current levels. It pointed to rising spending tied to the order backlog.Truist raised its target slightly to $85, implying about 12% upside, while noting continued questions around sustainable profitability. Stifel’s $110 target suggests potential upside of roughly 45%, while Deutsche Bank and DA Davidson both maintained $125 targets, representing gains of about 65%. Meanwhile, Evercore ISI’s revised $150 target implies nearly 98% upside from the last close.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for CRWV was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/crwv_ss_png_05e9b3fa4e.webp" alt="crwv ss.png" width="969" height="143"><figcaption>CRWV sentiment and message volume as of March 2 | Source: Stocktwits</figcaption></figure>One user said, “Great buy point here . $215 by the summer the backlog here is massive.”<stembedurl>https://stocktwits.com/Starnotes/message/646279590</stembedurl>Another user said, “Looks like AH will not be much of an indicator for CRWV with Trump's war in Iran. Same silly quick play for gold and silver that always taps out by time the bell opens. Will have to wait to see how tomorrow shapes up.”<stembedurl>https://stocktwits.com/LHTOP/message/646268898</stembedurl>CRWV stock has risen 11% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CoreWeave logo is displayed on a mobile phone, with the company's branding visible in the background, in this photo illustration in Brussels, Belgium, on November 10, 2025. 

CRWV Stock Slips Premarket After Michael Burry Revives Dot-Com Parallels — Wall Street Still Bets On Massive Upside

Wall Street remains optimistic on CoreWeave, with analyst targets implying potential upside ranging from about 12% to nearly 98% from current levels.

<ul class="summary-bullets"><li>The cheaper trim keeps the same dual-motor setup but cuts interior materials, comfort features, and suspension upgrades.</li><li>Despite modest U.S. sales of 20,000 units last year, delivery timelines now stretch into 2027.</li><li>Tesla also highlighted over 8.4 billion miles logged by its FSD Supervised system, inching closer to its unsupervised autonomy ambitions.&nbsp;</li></ul>Tesla, Inc. (TSLA) shares fell about 4% in overnight trading&nbsp;heading into Monday after the company raised the price of its newly introduced entry-level Cybertruck, reversing a brief period when the electric pickup was offered at its lowest-ever starting price.<h2 class="st-heading-2">Cybertruck Entry Price Jumps 17% In 10 Days</h2>Tesla launched its most affordable Cybertruck on Feb. 20 with a starting price of $59,990, positioning it below previous trims and closer to long-standing expectations of broader accessibility. However, effective March 1, the company increased the starting price to $69,990, marking a 17% jump and eliminating the temporary discount window that had lasted just 10 days.CEO Elon Musk had indicated at launch&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/2024817036241871001">on X</a> that the promotional pricing would be available only briefly, noting that the eventual price would depend on demand. The adjustment also returns the entry-level configuration to the same pricing level as the rear-wheel-drive version Tesla discontinued in September 2025. The company has also removed the lease option for the newly launched variant.<h2 class="st-heading-2">Tesla Resets Cybertruck Price Ladder</h2>With the latest revision, Tesla’s Cybertruck range resets across three tiers. The entry dual-motor all-wheel-drive (AWD) version now begins at $69,990, while the premium AWD trim remains priced at $79,990 and the tri-motor Cyberbeast sits at $99,990.When the Cybertruck was unveiled in 2019, Musk projected a starting price of about $39,990, with the most advanced configuration expected to begin near $70,000. When production finally began in November 2023, actual pricing entered the market well above those early projections.<h2 class="st-heading-2">Same Powertrain, Fewer Comforts</h2>The lower-priced variant retains the same dual-motor powertrain and roughly 325-mile estimated range as the premium AWD model, but its original cost savings were achieved through a simplified interior and reduced feature set.Compared with higher trims, it substitutes textile seating for premium materials, pares back audio and comfort features, and replaces air suspension with coil springs, while also removing certain cabin technology elements.<h2 class="st-heading-2">Cybertruck Demand Lags, Wait Times Stretch</h2>Cybertruck sales have so far fallen short of Tesla’s early ambitions. Around 20,000 units were sold in the U.S. last year, far below initial production targets. The company does not disclose Cybertruck deliveries separately; instead, it groups them within its “other models” category alongside the Model S and Model X.Despite this, updated ordering timelines now suggest delivery wait times stretching into 2027 for the entry AWD version in some U.S. regions.<h2 class="st-heading-2">FSD Progress In Focus</h2>Alongside pricing adjustments, Tesla highlighted progress in its Full Self-Driving Supervised (FSD) system, which has now logged more than 8.4 billion cumulative miles, according to company data. Musk has previously said that roughly 10 billion miles of real-world driving data may be needed to support safe unsupervised autonomy at scale.During Tesla’s fourth-quarter earnings call, Musk also said the Cybertruck platform could be used for autonomous intra-city cargo delivery, calling it suitable for short-distance urban logistics if consumer demand for the vehicle falls short of expectations.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Tesla was ‘extremely bullish’ amid ‘low’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/tsla_ss_png_e65aa3aa7b.webp" alt="tsla ss.png" width="968" height="140"><figcaption>TSLA sentiment and message volume as of March 2 | Source: Stocktwits</figcaption></figure>One user said, “THE GREAT TESLA PRETENDING ROBOTAXI HOAX WILL PULL TESLA DOWN TO LOW $100S WITH OR WITHOUT CURRENT INDEX COLLAPSE.”<stembedurl>https://stocktwits.com/hppie/message/646278721</stembedurl>Another user said they “Definitely see a recovery at some point later on today.”<stembedurl>https://stocktwits.com/Bonemealz/message/646276278</stembedurl>TSLA stock has declined 11% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tesla Stock Slides Overnight: Cheapest Cybertruck Price Jumps 17% Within 10 Days Of Launch

The starting price jumped from $59,990 on Feb. 20 to $69,990 effective March 1.

<ul class="summary-bullets"><li>February deliveries showed Lunar New Year disruption, with Firefly posting its second-weakest month since launch.</li><li>Firefly delivered 2,657 units, down 5.3% month-on-month, while total group deliveries rose 57.6% year-on-year to 20,797.</li><li>The flagship ES8 remained the key pillar, delivering 11,260 units and marking 54% of total volumes.</li></ul>Shares of Nio, Inc. (NIO) fell over 3% in Hong Kong on Monday after February delivery data underscored how an extended Lunar New Year holiday weighed on volumes across China’s EV sector, with the impact most visible in its Firefly sub-brand.<h2 class="st-heading-2">Holiday Disruption Hits Firefly</h2>Firefly delivered 2,657 vehicles in February, down 5.3% from January, marking the second-weakest month since deliveries began in May 2025. The weakness came as the 2026 Spring Festival holiday ran from Feb. 15 to 23, three days longer than last year. The holiday reduced the month to just 16 working days. February is typically one of the weakest months for production and sales across the auto industry, with this year’s extended holiday amplifying the slowdown.Despite Firefly’s positioning as Nio’s more affordable global entry brand, it remains a small contributor to group volumes, accounting for roughly 12% of cumulative deliveries since launch.At the group level, Nio delivered 20,797 vehicles in February, up 58% year-on-year but down 23% from January. Within this, the main Nio brand delivered 15,159 units, rising 66% year-on-year but falling 27% month-on-month.The company’s flagship third-generation ES8 continued to anchor performance. The premium SUV delivered 11,260 units in February, accounting for 54% of total deliveries and 74% of the main brand’s volume.Across January and February, ES8 deliveries&nbsp;totaled 28,918 units, representing over 60% of total deliveries and more than 80% of main-brand sales. However, ES8 volumes declined 36% from January.The ES8 remains central to Nio’s profitability, with its premium positioning supporting margin improvement as the company works toward its anticipated first quarterly profit ahead of earnings on March 10.<h2 class="st-heading-2">Incentives To Sustain Momentum</h2>To counter seasonal weakness, Nio introduced limited-time incentives, including a 10,000 yuan ($1,458) purchase tax subsidy and extended seven-year low-interest financing with down payments starting at 20%. Customers locking in orders before March 31 can also access complimentary driver assistance features and optional upgrades.<h2 class="st-heading-2">Rivals Also Feel February Chill</h2>XPeng delivered 15,256 vehicles in February, down 49.9% year-on-year and 23.76% month-on-month, reflecting both holiday disruptions and the gradual withdrawal of national support policies.&nbsp;In response to domestic softness, XPeng has been accelerating its international push, beginning global deliveries of its new P7+ model to 18 countries and preparing to launch its second-generation Vision-Language-Action software alongside the 2026 X9 MPV as part of its growth strategy.Meanwhile, Li Auto reported 26,421 deliveries for the month, down 4.5% sequentially but slightly higher year-on-year, ending nearly a year of declines even as the holiday constrained output.The company is also restructuring its retail network through a newly launched “Store Partner Program,” granting select managers operational autonomy and profit-sharing incentives&nbsp;to strengthen sales ahead of its next product cycle.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment toward Nio was ‘bearish’ and toward XPeng was ‘neutral’, both amid ‘normal’ message volume, while Li Auto drew ‘bullish’ sentiment alongside ‘high’ message volume.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/NIO">U.S.-listed shares of Nio</a> are down about 4.5%, and&nbsp;<a href="https://stocktwits.com/symbol/XPEV">XPeng</a> has fallen roughly 13%, while&nbsp;<a href="https://stocktwits.com/symbol/LI">Li Auto</a> has bucked the trend with a gain of around 4%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The NIO Ink logo is displayed on a mobile phone with the company branding seen in the background in this photo illustration in Brussels, Belgium, on November 9, 2025. (Photo by Jonathan Raa/NurPhoto via Getty Images)

Nio Stock Slides In Hong Kong As Holiday-Hit February Weighs On Firefly — XPeng, Li Auto Also Feel The Heat

XPeng deliveries fell year-on-year amid policy shifts, while Li Auto made retail restructuring plans through its new Store Partner Program.